8-K ·Filed Oct 16, 2026
8-K context-dependent: Items 5.02
Actionable Insight • Neutral
Routine board committee reshuffle with no operational or financial implications. No immediate trading catalyst.
Latest settled: T+5d
TCRX ▼ -9.75% at T+5d
NEUTRAL call -9.75% · α vs SPY -9.61% · entry $0.2102 → $0.1897
Latest observation: T+6 +18.95% FF3 residual α
T+1d
+6.57%
call +6.57% · α +6.23%
$0.2240
settled 9d ago
T+5d
-9.75%
call -9.75% · α -9.61%
$0.1897
settled 5d ago
T+20d
Pending
in 16d
T+60d
Pending
in 3mo
Price Chart
Loading chart...
Executive Summary
Two board members, Garry Nicholson and Gabriela Gruia, M.D., resigned from TScan Therapeutics' board effective October 13, 2026. The resignations were not due to any disagreement with the company, and replacements were appointed to committees. This is a routine board change with no material financial impact.
Key Facts
- Garry Nicholson and Gabriela Gruia, M.D., resigned from the Board of Directors effective October 13, 2026.
- Neither resignation was a result of any disagreement with the company.
- Stephen Biggar and R. Keith Woods were appointed to the Nominating and Corporate Governance Committee.
- The Audit Committee now consists of Katina Dorton, Barbara Klencke, and R. Keith Woods.
Financial Impact
No financial impact disclosed.
Risk Factors
- No material risks identified from this filing.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-424198 |
| Document: 0001193125-26-424198-index-headers.html | 0001193125-26-424198 |
| Document: 0001193125-26-424198-index.html | 0001193125-26-424198 |
| Document: 0001193125-26-424198.txt | 0001193125-26-424198 |
14 reports for TCRX
86% Hit rate @ T+20 Went positive at some point 7 of 8 best @ T+20▲ +58.87%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 1d ago | DEF 14A | $0.1897 | awaiting T+20 | awaiting T+20 | $0.1920 (−1.21%) |
Oct 16, 2026 11d ago | 8-K | $0.2102 | awaiting T+20 | awaiting T+20 | $0.1920 (−8.66%) |
Sep 30, 2026 27d ago | 8-K | $0.3175 | awaiting T+20 | awaiting T+20 | $0.1920 (−39.53%) |
Sep 25, 2026 4w ago | SC 13G | $0.3400 $0.1897 | ▼ −44.21% | ▼ −44.17% | $0.1920 (−43.53%) |
Sep 11, 2026 6w ago | 8-K | $0.3204 $0.2380 | ▼ −25.72% | ▼ −27.59% | $0.1920 (−40.07%) |
Sep 2, 2026 7w ago | 8-K | $0.3810 $0.3150 | ▲ +17.32% | ▲ +17.24% | $0.1920 (+49.61%) |
Aug 18, 2026 10w ago | 8-K | $0.7500 $0.3335 | ▲ +55.53% | ▲ +53.58% | $0.1920 (+74.40%) |
Aug 12, 2026 10w ago | 8-K | $0.7730 $0.3179 | ▲ +58.87% | ▲ +56.98% | $0.1920 (+75.16%) |
Aug 12, 2026 10w ago | Press Release | $0.7730 $0.3179 | ▲ +58.87% | ▲ +56.98% | $0.1920 (+75.16%) |
Jun 22, 2026 18w ago | 8-K | $0.8651 $0.9148 | ▲ +5.75% | ▲ +5.89% | $0.1920 (−77.81%) |
Showing 10 of 14
US Market Status
Market Closed · Opens in 4h 15m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers